Phibro Animal Health (NASDAQ:PAHC) reported Q1 CY2026 revenue of $347.8 million, missing analysts’ estimates of $359.7 million. Adjusted EPS of $0.63 fell 8.3% below expectations. Full-year revenue guidance is $1.46 billion, close to analyst estimates. Over the last 5 years, revenue grew at a 11.9% CAGR. Operating margin increased to 11.4% in Q1. EPS grew at a 17.1% CAGR. Despite missing estimates this quarter, analysts expect 6% revenue growth in the next 12 months. Full research report available for active Edge members. Market capitalization is $1.51 billion.

Read more at StockStory Media: Phibro Animal Health (NASDAQ:PAHC) Reports Sales Below Analyst Estimates In Q1 CY2026 Earnings